Published in J Neurol on April 01, 1992
A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol (1994) 2.83
Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain. Am J Pathol (1999) 0.91
Evidence that neurofibrillary tangles undergo glial modification. Acta Neuropathol (1992) 0.87
Focal expression of mutated tau in entorhinal cortex neurons of rats impairs spatial working memory. Behav Brain Res (2010) 0.85
Specific human astrocyte subtype revealed by affinity purified GFAP antibody; unpurified serum cross-reacts with neurofilament-L in Alzheimer. PLoS One (2009) 0.80
Paired helical filaments and straight tubules in astrocytes: an electron microscopic study in dementia of the Alzheimer type. Acta Neuropathol (1995) 0.80
Dipeptidyl peptidase 10 (DPP10(789)): a voltage gated potassium channel associated protein is abnormally expressed in Alzheimer's and other neurodegenerative diseases. Biomed Res Int (2014) 0.78
Immunohistochemical analysis of ubiquilin-1 in the human hippocampus: association with neurofibrillary tangle pathology. Neuropathology (2013) 0.77
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology (2007) 2.86
Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease? Clin Neuropathol (1985) 2.72
Defective immune-adherence (C3b) receptor on erythrocytes from patients with systemic lupus erythematosus. Lancet (1981) 2.64
Lewy bodies in cerebral cortex, report of three cases. Acta Neuropathol (1978) 2.41
Presence of 2 different viral agents in brain cells of patients with subacute sclerosing panencephalitis. Proc Soc Exp Biol Med (1970) 2.20
Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia (1984) 1.99
Effect of beta and beta2 adrenoreceptor stimulants infused intrapancreatically on glucagon and insulin secretion. Endocrinology (1975) 1.67
Subacute sclerosing panencephalitis: structures resembling myxovirus nucleocapsids in cells cultured from brain. Nature (1969) 1.62
Comparison of subacute sclerosing panencephalitis and measles viruses: an electron microscope study. J Virol (1971) 1.61
Effects of stimulation of the vagus nerve on insulin secretion. Endocrinology (1967) 1.53
A neuropathological study of the disturbance of the nigro-amygdaloid connections in brains from patients with dementia with Lewy bodies. J Neurol Sci (2001) 1.51
A human proinsulin variant at arginine 65. Nature (1981) 1.49
The features of causes of death in Japanese diabetics during the period 1971-1980. Tohoku J Exp Med (1983) 1.48
Tunable Dirac cone in the topological insulator Bi(2-x)Sb(x)Te(3-y)Se(y). Nat Commun (2012) 1.45
Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care (1993) 1.44
Presenile dementia with Alzheimer-, Pick- and Lewy-body changes. Acta Neuropathol (1976) 1.44
Familial myoclonus epilepsy and choreoathetosis: hereditary dentatorubral-pallidoluysian atrophy. Neurology (1982) 1.42
Effect of combination therapy of troglitazone and sulphonylureas in patients with Type 2 diabetes who were poorly controlled by sulphonylurea therapy alone. Diabet Med (1996) 1.42
Alterations of muscarinic acetylcholine receptor subtypes in diffuse lewy body disease: relation to Alzheimer's disease. J Neurol Neurosurg Psychiatry (1999) 1.41
Association between HLA and islet cell antibodies in diabetic patients with a mitochondrial DNA mutation at base pair 3243. Diabetologia (1996) 1.38
The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care (1983) 1.32
Electrical activity of red nucleus neurones investigated with intracellular microelectrodes. Exp Brain Res (1967) 1.30
A duplicated PLP gene causing Pelizaeus-Merzbacher disease detected by comparative multiplex PCR. Am J Hum Genet (1996) 1.26
Insulin responses in equivocal and definite diabetes, with special reference to subjects who had mild glucose intolerance but later developed definite diabetes. Diabetes (1977) 1.25
Catecholaminergic neurons containing GABA-like and/or glutamic acid decarboxylase-like immunoreactivities in various brain regions of the rat. Exp Brain Res (1987) 1.24
Cell mediators of inflammation in the Alzheimer disease brain. Alzheimer Dis Assoc Disord (2000) 1.22
A clinical and pathologic study of a large Japanese family with Machado-Joseph disease tightly linked to the DNA markers on chromosome 14q. Neurology (1994) 1.21
Insulin secretory response of diabetics during the period of improvement of glucose tolerance to normal range. Diabetologia (1974) 1.21
Membranous glomerulonephritis associated with eosinophilic lymphfolliculosis of the skin (Kimura's disease): report of a case and review of the literature. Clin Nephrol (1982) 1.20
Electron microscopic observations in subacute sclerosing panencephalitis brain cell cultures: their correlation with cytochemical and immunocytological findings. J Virol (1970) 1.17
Granulocytosis and colony-stimulating activity (CSA) produced by a human squamous cell carcinoma. Cancer (1979) 1.15
Axons and axon terminals of cerebellar Purkinje cells and basket cells have higher levels of parvalbumin immunoreactivity than somata and dendrites: quantitative analysis by immunogold labeling. Exp Brain Res (1993) 1.15
Early senile plaques in Down's syndrome brains show a close relationship with cell bodies of neurons. Neuropathol Appl Neurobiol (1990) 1.15
Expression of CD40 in the brain of Alzheimer's disease and other neurological diseases. Brain Res (2000) 1.14
Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients. Mol Psychiatry (2002) 1.13
Insulin binding and glucose metabolism in adipocytes of streptozotocin-diabetic rats. Am J Physiol (1978) 1.12
Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions. Gastroenterology (1990) 1.11
The mode of cerebral excitation of red nucleus neurons. Exp Brain Res (1968) 1.10
[An autopsy case of unclassifiable presenile dementia]. Seishin Shinkeigaku Zasshi (1973) 1.10
Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia. J Neurochem (1984) 1.10
Distinctive, rapid, and easy labeling of diffuse plaques in the Alzheimer brains by a new methenamine silver stain. Acta Neuropathol (1990) 1.10
Heterogeneous relationship of early insulin response and fasting insulin level with development of non-insulin-dependent diabetes mellitus in non-diabetic Japanese subjects with or without obesity. Diabetes Res Clin Pract (1999) 1.10
Plasma insulin response to intravenously administered xylitol in dogs. Metabolism (1966) 1.09
Health risks among Japanese men with moderate body mass index. Int J Obes Relat Metab Disord (2000) 1.09
Plasma insulin responses to glucose in femoral, hepatic, and pancreatic veins in dogs. Am J Physiol (1966) 1.09
A mutation in the beta 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun (1995) 1.08
Association of HLA-A24 with complete beta-cell destruction in IDDM. Diabetes (1993) 1.08
Effects of vagal stimulation on glucagon and insulin secretion. Endocrinology (1974) 1.08
Low serum potassium levels and risk of type 2 diabetes: the Toranomon Hospital Health Management Center Study 1 (TOPICS 1). Diabetologia (2011) 1.07
[A cliniconeurophathological study of the "Lewy body disease"]. Seishin Shinkeigaku Zasshi (1980) 1.06
Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment. Diabetologia (1980) 1.06
Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease. Neurosci Lett (1999) 1.06
Brain site-specific gene expression analysis in Alzheimer's disease patients. Eur J Clin Invest (2006) 1.05
The pharmacokinetics of insulin after continuous subcutaneous infusion or bolus subcutaneous injection in diabetic patients. Diabetes (1983) 1.05
Establishment of immortalized dental follicle cells for generating periodontal ligament in vivo. Cell Tissue Res (2006) 1.04
Synaptic excitation of red nucleus neurones by fibres from interpositus nucleus. Exp Brain Res (1970) 1.04
Effects of fasting and refeeding of insulin receptors and glucose metabolism in rat adipocytes. Endocrinology (1977) 1.04
High glycosylated hemoglobin levels increase the risk of progression to diabetes mellitus in subjects with glucose intolerance. Diabetes Res Clin Pract (1996) 1.04
Effect of bombesin infused intrapancreatically on glucagon and insulin secretion. Metabolism (1978) 1.03
GABAergic neurons containing CCK-8-like and/or VIP-like immunoreactivities in the rat hippocampus and dentate gyrus. J Comp Neurol (1985) 1.03
High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease. Clin Chim Acta (1992) 1.02
Decline of postheparin plasma lipoprotein lipase in acromegalic patients. Metabolism (1980) 1.02
Quantitative analysis of GABA-like-immunoreactive and parvalbumin-containing neurons in the CA1 region of the rat hippocampus using a stereological method, the disector. Exp Brain Res (1994) 1.02
Histopathology and electron microscopy of three cases of subacute sclerosing panencephalitis (SSPE). Acta Neuropathol (1971) 1.01
Myotonic dystrophy and thymoma: a necropsy case report. J Neurol Neurosurg Psychiatry (1981) 1.01
Up-regulation of calcineurin Abeta mRNA in the Alzheimer's disease brain: assessment by cDNA microarray. Biochem Biophys Res Commun (2001) 1.01
Intraglomerular dendritic link connected by gap junctions and chemical synapses in the mouse main olfactory bulb: electron microscopic serial section analyses. Neuroscience (2005) 1.00
Language production in Parkinson's disease: acoustic and linguistic considerations. Brain Lang (1988) 1.00
Direct measurement of the out-of-plane spin texture in the Dirac-cone surface state of a topological insulator. Phys Rev Lett (2011) 1.00
Effect of splanchnic nerve stimulation on glucagon and insulin output in the dog. Endocrinology (1975) 1.00
Pituitary apoplexy in acromegaly during bromocriptine therapy. Acta Endocrinol (Copenh) (1981) 0.99
Relation of the course of retinopathy to control of diabetes, age, and therapeutic agents in diabetic Japanese patients. Diabetes (1969) 0.99
[Distribution of Pick bodies in the central nervous system of Pick's disease with special reference to their association with neuronal loss]. Seishin Shinkeigaku Zasshi (1987) 0.99
Exocrine pancreatic ductograms in insulin-dependent diabetes mellitus. Am J Gastroenterol (1994) 0.99
Relationships among residual beta cells, exocrine pancreas, and islet cell antibodies in insulin-dependent diabetes mellitus. Metabolism (1993) 0.98
[An autopsy case of atypical presenile dementia with morphological features of Alzheimer's diseases and Pick's disease]. Seishin Shinkeigaku Zasshi (1975) 0.98
Efficient synthesis and secretion of a thermophilic alpha-amylase by protein-producing Bacillus brevis 47 carrying the Bacillus stearothermophilus amylase gene. J Bacteriol (1985) 0.98
The formation of prostaglandins in the postmortem cerebral cortex of Alzheimer-type dementia patients. J Neurol (1989) 0.97
An electron microscopic study on the fine structures of cerebral cortex in the mice infected with Japanese encephalitis virus. Neuropatol Pol (1967) 0.97
Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes (1996) 0.97
[Metabolism and effects of vasoactive substance in the lung. 10. Effects of calcium antagonist, verapamil, on the smooth muscle of the trachea]. Nihon Kyobu Shikkan Gakkai Zasshi (1976) 0.96
Epworth Sleepiness Scale and sleep studies in patients with obstructive sleep apnea syndrome. Psychiatry Clin Neurosci (1999) 0.96
Nasu-Hakola's disease (membranous lipodystrophy). A case report. Acta Neuropathol (1981) 0.95
Electron microscopic observations in mice infected with Japanese encephalitis. Acta Neuropathol (1969) 0.95
Stimulation of insulin secretion by parasympathomimetic agents. Endocrinology (1968) 0.95
Isoproterenol-stimulated C-peptide and insulin secretion in diabetic and nonobese normal subjects: decreased hepatic extraction of endogenous insulin in diabetes. J Clin Endocrinol Metab (1980) 0.94
Effects of antiinsulin receptor autoantibody on the metabolism of rat adipocytes. J Clin Endocrinol Metab (1978) 0.94
In situ characterization of islets in diabetes with a mitochondrial DNA mutation at nucleotide position 3243. Diabetes (1997) 0.94
A non-alcoholic Japanese patient with Wernicke's encephalopathy and Marchiafava-Bignami disease. Clin Neuropathol (1985) 0.94
An early cytoplasmic change before Lewy body maturation: an ultrastructural study of the substantia nigra from an autopsy case of juvenile parkinsonism. Acta Neuropathol (1993) 0.94
Argyrophilic thread-like structure in corticobasal degeneration and supranuclear palsy. Neurosci Lett (1994) 0.94
Degenerative terminals of the perforant pathway are human alpha-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease. Neurosci Lett (1998) 0.93
An autopsy case of Alzheimer's disease presenting with primary progressive aphasia: a clinicopathological and immunohistochemical study. Neuropathology (2000) 0.93